This divergent evidence may be due to the different experimental conditions of the studies
Plans could see real savings, Fendrick said, if they covered GLP-1s for initial weight loss then moved people to cheaper options such as more affordable drugs or behavioral health programs to maintain it
Starting your GLP-1 protocol Whether you access GLP-1 medications through insurance or through alternative channels, the starting process follows similar patterns
Or start upstream and take the Precision Peptide Genetic Test to map your GLP-1 pathway first
Wegovy has been approved by the FDA to reduce risk of major adverse cardiovascular events (MACE) in those with a history of MACE, but studies of Zepbound are still pending
PubMed, Kulanuwat, Sirikul, et al